Terrence Mullen

Raising first-time funds is hard, but placing capital with big established managers you haven’t previously backed is also hard.

GPs that fail to deeply examine their strengths and weaknesses on a regular basis may be headed for disappearance.

Why LPs appreciate a steady flow of information not tied to a specific capital commitment request.

Three experts of the fundraising market discuss the importance of uncovering a GP’s unique story.

Why Arsenal Capital is so excited about the innovative companies it backs.

How two of Arsenal’s first three deals provided painful lessons.

Small businesses need to become “small giants” by tapping the resources, expertise and networks that a private equity firm can provide, according to Terrence Mullen, a Partner at New York-based Arsenal Capital Partners.

Terrence Mullen of Arsenal Capital Partners discusses the thesis behind his firm’s investment in chemical company Chromaflo.

Topics include why U.S. middle-market companies must face global opportunities, what tools GPs can bring to their portfolio companies to help them go global, and more.

A long-term trend in private equity is for limited partners to seek to co-invest directly in deals alongside their general partners.

Three experts discuss the state of lending in the U.S. middle market, the difference between cash-flow and asset-based lending, being transparent with lenders, and the way leverage affects returns.

Topics discussed include the changing sources of deal opportunities, the aftermath of the 2008 downturn, the need for industry and operations expertise, and the effect that downsized megafirms will have on middle-market deal flow.

Three fundraising experts discuss the opportunities and challenges in today’s private equity capital-formation market.